CN108957787B - Full-correction glasses lens for improving amblyopia or preventing astigmatism and vision deterioration and therapeutic apparatus - Google Patents
Full-correction glasses lens for improving amblyopia or preventing astigmatism and vision deterioration and therapeutic apparatus Download PDFInfo
- Publication number
- CN108957787B CN108957787B CN201811139815.2A CN201811139815A CN108957787B CN 108957787 B CN108957787 B CN 108957787B CN 201811139815 A CN201811139815 A CN 201811139815A CN 108957787 B CN108957787 B CN 108957787B
- Authority
- CN
- China
- Prior art keywords
- lens
- astigmatism
- full
- vision
- correction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 201000009310 astigmatism Diseases 0.000 title claims abstract description 101
- 238000012937 correction Methods 0.000 title claims abstract description 69
- 230000004438 eyesight Effects 0.000 title claims abstract description 68
- 201000009487 Amblyopia Diseases 0.000 title claims abstract description 61
- 230000006866 deterioration Effects 0.000 title claims abstract description 49
- 230000001225 therapeutic effect Effects 0.000 title claims abstract description 13
- 239000011521 glass Substances 0.000 title claims description 25
- 208000001491 myopia Diseases 0.000 claims abstract description 26
- 230000004379 myopia Effects 0.000 claims abstract description 15
- 230000002093 peripheral effect Effects 0.000 claims abstract description 8
- 208000014733 refractive error Diseases 0.000 claims abstract description 8
- 230000003287 optical effect Effects 0.000 claims abstract description 7
- 230000002159 abnormal effect Effects 0.000 claims description 7
- 239000008186 active pharmaceutical agent Substances 0.000 claims description 7
- 230000004308 accommodation Effects 0.000 claims description 5
- 230000002265 prevention Effects 0.000 claims description 4
- 230000000694 effects Effects 0.000 abstract description 32
- 208000029091 Refraction disease Diseases 0.000 abstract description 3
- 230000004430 ametropia Effects 0.000 abstract description 3
- 238000011161 development Methods 0.000 description 14
- 230000000052 comparative effect Effects 0.000 description 10
- 206010020675 Hypermetropia Diseases 0.000 description 9
- 201000006318 hyperopia Diseases 0.000 description 9
- 230000004305 hyperopia Effects 0.000 description 9
- 238000000034 method Methods 0.000 description 7
- 208000002111 Eye Abnormalities Diseases 0.000 description 3
- 230000002411 adverse Effects 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000002604 ultrasonography Methods 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 210000001525 retina Anatomy 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 230000008719 thickening Effects 0.000 description 2
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 208000004350 Strabismus Diseases 0.000 description 1
- 208000034700 Vitreous opacities Diseases 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 208000030533 eye disease Diseases 0.000 description 1
- 210000000744 eyelid Anatomy 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000004423 myopia development Effects 0.000 description 1
- 230000009707 neogenesis Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 201000010041 presbyopia Diseases 0.000 description 1
- 210000003786 sclera Anatomy 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Classifications
-
- G—PHYSICS
- G02—OPTICS
- G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
- G02C7/00—Optical parts
- G02C7/02—Lenses; Lens systems ; Methods of designing lenses
- G02C7/06—Lenses; Lens systems ; Methods of designing lenses bifocal; multifocal ; progressive
-
- G—PHYSICS
- G02—OPTICS
- G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
- G02C7/00—Optical parts
- G02C7/02—Lenses; Lens systems ; Methods of designing lenses
- G02C7/024—Methods of designing ophthalmic lenses
Landscapes
- Health & Medical Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Prostheses (AREA)
- Eyeglasses (AREA)
Abstract
The invention provides an ophthalmic lens and a therapeutic instrument for improving amblyopia or preventing astigmatism and vision deterioration by full correction, belonging to the technical field of optical lenses for eye health care and treatment. The periphery of the light area is a peripheral light area; the optical zone is a full-correction lens for correcting the ametropia, and comprises a far-vision or myopia lens and a first astigmatism full-correction lens; the astigmatism of the first astigmatic full-correction foot lens is kDC, wherein the value range of k is-8 to +8; the peripheral light area S2 is a first non-corrective lens, and the diopter B1 takes the value of: (1/2) kDS < B1 < +10DS; or the surrounding light area S2 is a second astigmatic full-correction lens and a second non-correction lens, wherein the astigmatism degree of the second astigmatic full-correction lens is the same or basically the same as that of the first astigmatic full-correction lens. The invention solves the problems existing in the prior art and has good effects of better improving amblyopia and preventing astigmatism from developing.
Description
Technical Field
The invention belongs to the technical field of optical lenses for eye care and treatment.
Background
In the face of amblyopia, astigmatism and vision deterioration, only ordinary vision correction lenses exist in the past, and the technology for solving the astigmatism development problem is not available, but only ordinary lens matching and astigmatism correction technologies exist. Because astigmatism is considered to be an congenital problem, an error theory irrelevant to an acquired factor exists (a common lens matching does not solve the problem of the back adjustment of eye abnormality, which can lead to difficult improvement of amblyopia and occurrence and development of astigmatism, the acquired factor of the development of astigmatism), and the existing low-degree astigmatism is called physiological astigmatism, and the like, the existing low-degree astigmatism is not considered to be an attention-free astigmatism, the development of astigmatism is not considered to be controlled and the problem of amblyopia is improved aiming at the astigmatism, the astigmatism is not considered to be controlled when the lens matching is carried out, the low-degree astigmatism is not corrected, the high-degree astigmatism is not corrected, or the lens matching problem of the astigmatism which is converted into far vision and near vision is adopted, and theoretical guidance errors exist in the lens matching of the near vision, for the correction of the low-degree astigmatism, for example, the prior art is in correcting the ametropia refractive error: current textbooks and many authoritative ophthalmic tool instructions, eye pathology, etc. require less power for prescription correction, which is not enough, but less enough, and still myopia is defined as the cause of lens thickening due to near accommodation, misunderstanding of less correction can prevent lens thickening. The theory and technique of the preparation can cause the problems of abnormal reverse regulation and the like of eyes for a long time, and the problems of poor improvement effect on amblyopia, especially amblyopia caused by astigmatism, are not found to be caused by astigmatism, and the problems of astigmatism, amblyopia and abnormal regulation of eyes are not recognized to be closely related to each other. In addition, the prior art does not take into account the correction of astigmatism in the peripheral light zone, which also results in astigmatism and vision deterioration. Therefore, the prior art for controlling astigmatism and amblyopia has great defects and many errors, and causes the problems of astigmatism development, amblyopia difficult improvement, vision deterioration and the like.
Disclosure of Invention
The invention aims to provide an ophthalmic lens and a therapeutic apparatus for improving amblyopia or preventing astigmatism and vision deterioration by full correction, which solve the problems in the prior art and have good effects of better improving amblyopia and preventing astigmatism development and vision deterioration.
In order to achieve the above purpose, the invention adopts the following technical scheme: an ophthalmic lens for improving amblyopia or preventing astigmatism and vision deterioration is provided, which is characterized in that a light zone S1 is arranged on the lens, and the surrounding of the light zone S1 is a surrounding light zone S2; the optical zone S1 is a full-correction lens with refractive errors, and comprises a far-vision or near-vision full-correction lens with first astigmatism; the diopter B of the far-sight or near-sight full-correction foot lens is larger than or equal to a conventional optometry value, the diopter of the first astigmatism full-correction foot lens is kDC, and the value range of k is-8 to +8, and k is not 0; the peripheral light area S2 is a first non-corrective lens, and the diopter B1 of the first non-corrective lens is as follows: (1/2) kDS < B1 < +10DS; or: the surrounding light area S2 is a second astigmatic full-correction lens and a second non-correction lens, the astigmatism degree of the second astigmatic full-correction lens is the same or basically the same as that of the first astigmatic full-correction lens (basically the same refers to that the astigmatism degree and the astigmatism degree are different by not more than 20 percent of the first astigmatic full-correction lens), and the diopter B2 of the second non-correction lens is in the range of 0.25 DS-10 DS; the total area of the spectacle lens is more than 900 square millimeters.
Solves the problems existing in the prior art, and has good effects of better improving amblyopia and preventing astigmatism from developing and vision deterioration.
Preferably, the far vision is more than or equal to the conventional optometry value of 0 DS-0.5 DS; the near vision is more than or equal to the normal optometry value of 0 DS-0.5 DS.
Preferably, the area of the light region S1 is < 700 square millimeters.
Preferably, the area of the light region S1 is < 600 square millimeters.
An all-corrected glasses lens for improving amblyopia or preventing astigmatism and vision deterioration, characterized by comprising 2 glasses lenses for improving amblyopia or preventing astigmatism and vision deterioration as described in the above, and the 2 glasses lenses are integrated into one large lens. Preferably, the lower part is provided with a structure which is anastomotic with the nose; the spectacle lens is a press-fit spectacle lens or a Fresnel lens.
An ophthalmic lens for improving amblyopia or preventing astigmatism and vision deterioration, characterized in that it is a contact lens comprising the structure of the ophthalmic lens for improving amblyopia or preventing astigmatism and vision deterioration as described above.
Glasses for improving amblyopia or preventing astigmatism and vision deterioration, characterized in that it is a common glasses or hanging glasses comprising the glasses for improving amblyopia or preventing astigmatism and vision deterioration as described above.
A therapeutic apparatus for improving amblyopia or preventing astigmatism and vision deterioration by full correction, comprising an ophthalmic lens for improving amblyopia or preventing astigmatism and vision deterioration by full correction as described above, said therapeutic apparatus comprising: a desk-type read-write instrument, a read-write myopia prevention instrument or a therapeutic instrument with a bracket, which is arranged on a desk.
The principle of the invention is as follows: the present inventors have found that conventional lens prescription techniques do not solve the problem of the back accommodation of the eye abnormalities of the human eye due to refractive errors and under-correction or under-correction during correction, which may result in astigmatism and vision deterioration, and mask the intrinsic real power of the eye, which is an important acquired factor for the development of astigmatism (full correction meaning: 1, far vision, near vision and astigmatism equal to or greater than the prescription value of conventional prescription after examination, but not less than, in order to eliminate the abnormal back accommodation of the eye, the corrected vision may reach a maximum of amblyopia between 0.01 and 0.8 or the non-amblyopia eye may be corrected to a normal vision range of between 0.8 and 2.0 or more), and full correction diopter is greater than or equal to the diopter which should be increased by removing the back accommodation of the eye abnormalities of the eye due to the long-term under-correction. 2. Refractive terms that do not have an absence of correction or an artificial amount of correction, such as hyperopia, myopia, astigmatism, qu Guangxiang and amount of strabismus. Thus, the amblyopia can be effectively improved, the astigmatism can be prevented from developing, and 3, the effect of far exceeding the previous method for preventing diopter deterioration such as abnormal eye axis development can be achieved through full correction of the central area of the retina and special correction (including non-correction) of the peripheral area of the retina.
The invention has the beneficial effects that: an ophthalmic lens for improving amblyopia and preventing the development of astigmatism and vision deterioration by full correction is provided to solve the problems existing in the prior art, has excellent effects of better improving amblyopia and preventing the development of astigmatism, and can also prevent the vision deterioration caused by diopter deterioration such as the development of abnormal eye axis.
Drawings
In order to more clearly illustrate the technical solutions of the embodiments of the present invention, the drawings that are needed in the embodiments or the description of the prior art will be briefly described below, it being obvious that the drawings in the following description are only some embodiments of the present invention, and that other drawings may be obtained according to these drawings without inventive effort for a person skilled in the art.
Fig. 1 is a schematic structural diagram of embodiment 1 of the present invention.
Fig. 2 is a schematic structural diagram of embodiment 2 of the present invention.
Fig. 3 is a schematic structural diagram of embodiment 3 of the present invention.
Wherein, each reference sign in the figure: s1-an optical area; s2-ambient light region.
Detailed Description
In order to make the technical problems, technical schemes and beneficial effects to be solved more clear, the invention is further described in detail below with reference to the accompanying drawings and embodiments. It should be understood that the specific embodiments described herein are for purposes of illustration only and are not intended to limit the scope of the invention.
Referring to fig. 1 and 2 together, the present invention will now be described. An ophthalmic lens for improving amblyopia or preventing astigmatism and vision deterioration is provided, which is characterized in that a light zone S1 is arranged on the lens, and the surrounding of the light zone S1 is a surrounding light zone S2; the optical zone S1 is a full-correction lens with refractive errors, and comprises a far-vision or near-vision full-correction lens with first astigmatism; the diopter B of the far-vision or near-vision full-correction foot lens is larger than or equal to a conventional optometry value, the diopter B of the far-vision or near-vision full-correction foot lens ranges from-15 DS to +10DS, the astigmatism of the first astigmatism full-correction foot lens is kDC, wherein the value range of k is-8 to +8, and k is not 0; the peripheral light area S2 is a first non-corrective lens, and the diopter B1 of the first non-corrective lens is as follows: (1/2) kDS < B1 < +10DS.
As a specific embodiment of the present invention. On the basis of the above, or: the surrounding light area S2 is a second astigmatic full correction lens and a second non-correction lens, the astigmatism degree of the second astigmatic full correction lens is the same or basically the same as that of the first astigmatic full correction lens (basically the same refers to that the difference between the astigmatism degree and the astigmatism degree is not more than 20 percent of the difference), and the diopter B2 of the second non-correction lens ranges from 0.25DS to 10DS; the total area of the spectacle lens is more than 900 square millimeters. As a specific embodiment of the present invention.
The geometric center refers to the center of a regular geometric shape; the theoretical geometric center refers to the intersection point of a parallel line of the midpoint of the distance between two horizontal lines of the upper and lower outermost edges of the irregular geometric shape and a vertical line of the midpoint of the distance between two vertical lines of the left and right outermost edges.
The invention has the excellent effects of better improving amblyopia and preventing the development of astigmatism, and can also prevent diopter deterioration such as vision deterioration caused by abnormal eye axis development.
As a specific embodiment of the present invention. Preferably, the distance vision is overcorrected, i.e. greater than the range of prescription values from 0DS to 0.5DS; the overcorrection range of myopia is 0DS to-0.5 DS. The effect is better.
As a specific embodiment of the present invention. See fig. 2. An all-corrected glasses lens for improving amblyopia or preventing astigmatism and vision deterioration, characterized by comprising 2 glasses lenses for improving amblyopia or preventing astigmatism and vision deterioration as described in the above, and the 2 glasses lenses are integrated into one large lens. The effect is better.
As a specific embodiment of the present invention. See fig. 3. Preferably, the lower part is provided with a structure which is anastomotic with the nose; the spectacle lens is a press-fit spectacle lens or a Fresnel lens.
As a specific embodiment of the present invention. An ophthalmic lens for improving amblyopia or preventing astigmatism and vision deterioration, characterized in that it is a contact lens comprising the structure of the ophthalmic lens for improving amblyopia or preventing astigmatism and vision deterioration as described above. The effect is better.
As a specific embodiment of the present invention. Glasses for improving amblyopia or preventing astigmatism and vision deterioration, characterized in that it is a common glasses or hanging glasses comprising the glasses for improving amblyopia or preventing astigmatism and vision deterioration as described above.
As a specific embodiment of the present invention. A therapeutic apparatus for improving amblyopia or preventing astigmatism and vision deterioration by full correction, comprising an ophthalmic lens for improving amblyopia or preventing astigmatism and vision deterioration by full correction as described above, said therapeutic apparatus comprising: a desk-type read-write instrument, a read-write myopia prevention instrument or a therapeutic instrument with a bracket, which is arranged on a desk. The effect is better.
Some example structures of the invention are shown in Table 1.
TABLE 1
Description:
1. Table 1 shows 8 examples of astigmatism C1 and associated presbyopia or near vision. B is the diopter of the far-sight or near-sight full-correction foot lens; b1 is the diopter of the first non-corrective lens; b2 is the diopter of the second non-corrective lens; c1 is the astigmatism of the first astigmatic full-correction foot lens; c2 is the astigmatism of the second astigmatic full foot lens.
2. The refractive index results of the eyes at conventional optometry are shown in brackets, from which the prescription parameters C1 and B in the lenses of the invention are made on S1.
3. The actual measured power in S1 and S2 is the value measured by the lensometer after the actual lens is made, the measured value and the design parameter value have a certain difference, the effect is not affected, and L is the actual measured prism, and the effect is not affected.
4. The total area of the spectacle lens is more than 900 square millimeters.
Clinical laboratory reporting of the invention
1. Experimental grouping:
The invention is compared with the prior patent technology applied to the multi-element lens with the ZL201210196959.8 for controlling defocus and eye diopter, and is divided into an experimental group and a comparison group.
1) First comparative group: patients with 3-9 years old teenagers with amblyopia (with ametropia) (with corrected vision of 0.4 and below, mild amblyopia and feeble persons were not study subjects), 50 subjects according to the invention, and 50 subjects in the comparative group.
2) Second comparative group: the teenagers aged 6-14 years had astigmatism plus myopia patients, 100 in the experimental group of the invention, and 100 in the comparative group.
3) Third comparative group: teenager astigmatism plus hyperopia patients 5-15 years old, 25 in the experimental group of the invention, and 25 in the comparative group.
2. The experimental method comprises the following steps: the glasses are prepared according to the respective regulations and are worn all the day. Experimental time: and checking the results after six months in two years, and comparing.
Within six months of two years, check once a month: vision, optometry, shadow detection, B-ultrasound of the eye and vision correction standard examination.
3. Experimental results:
a) efficacy standard:
1) For amblyopia (weak amblyopia with corrected vision more than 0.4 is not a study object, because the weak amblyopia is possibly improved by common glasses or no glasses, the effect is not clear)
The effect is shown: for weak vision objective diopter degree is lower than average increment degree of same age, the standard international logarithmic visual chart for correcting vision can be used for checking vision, and its improvement is obvious by 5 lines and above.
The method is effective: the objective diopter of refraction is lower than the average increase degree of the same age, and 3 lines or more of vision improvement is effectively corrected.
Invalidation: the objective diopter of refraction is equal to the average increment degree of the same age, and the vision correction is improved by 2 lines and below without definite effect, and the vision correction is ineffective.
2) For astigmatism (including concomitant myopia and hyperopia)
The effect is shown: the increase in objective diopter (each of the three aspects of astigmatism, myopia and hyperopia) is less than half the average increase in age and more, and is significant.
The method is effective: an objective diopter addition (each of the three aspects of astigmatism, myopia, and hyperopia) lower than the average increase in age-related is effective.
Invalidation: an increase in objective diopter power (each of the three aspects of astigmatism, myopia and hyperopia) equal to the average increase in the same age was ineffective.
3) For vision deterioration (vision deterioration due to diopter increase, amblyopia, and B ultrasonic display of eye axis increase, vitreous opacity, posterior sclera deformation, etc.)
The effect is shown: the increase of the objective diopter (each of astigmatism, myopia and hyperopia) is less than half of the average increase of the same age and more, and the B-ultrasonic display has no new problem and no amblyopia trend, and is obvious.
The method is effective: the increase in objective diopter power (each of the three aspects of astigmatism, myopia and hyperopia) is lower than the average increase in age, and the ultrasound B shows no neogenesis problem, no amblyopia trend, is effective.
Invalidation: the objective diopter addition (each of astigmatism, myopia, and hyperopia) is equal to the average increase in age, and the B-mode ultrasound shows a new problem, a weak vision tendency, and is ineffective.
Second) checking results:
1) First comparative group:
the experimental group shows 23 persons, 50 persons, 0 person, and 100% of effective rate.
Comparison group: has 0 person of obvious effect, 12 persons of effective effect, 38 persons of ineffective effect and 24% of effective rate.
2) Second comparative group:
The experimental group shows 88 persons with effectiveness, 98 persons with effectiveness, 2 persons with effectiveness, and the effective rate is 98%.
Comparison group: the effective rate is 5, 39, 61 and 39 percent.
3) Third comparative group:
the experimental group shows 20 persons, 25 persons, 0 person, and 100% of effective rate.
Comparison group: has 0 person of obvious effect, 7 persons of effective effect, 18 persons of ineffective effect and 28% of effective rate.
Third), analysis of results:
Invalid instance analysis: the objective causes are genetic factors and eyelid serious occlusion factors. Subjective causes are related to poor ocular behavior habits. In our experiments, it was required to correct bad habits such as sitting position correction, prohibition of long-time use of electronic products, etc. for all participants, and although the requirements are strict, there are problems that supervision is not in place, children do not hear, parents do not carefully cooperate. This has an adverse effect on the experimental results, which will be of great importance in future applications, and attention is paid here in particular.
In the aspect of comparing the astigmatism and amblyopia prevention and treatment effects, the effect of the invention is clear and obvious, the prior method has no design for preventing astigmatism, and the problems of increasing the occurrence and development of astigmatism are also solved. The contrast group has adverse problems such as reverse regulation, and the designed diopter parameter is unreasonable and even plays a role in adverse effect, so that astigmatism can be caused, and the effects of improving amblyopia and controlling myopia development are also affected. For far vision, the vision should not be reduced, but vision should be maintained and focused on improvement. There is also an erroneous design in comparison with similar prior art. The conventional effect statistics have errors for controlling the vision deterioration effect caused by diopter, and are relatively not ideal.
Conclusion: the invention has remarkable effects on improving amblyopia and preventing astigmatism and vision deterioration compared with the comparative group.
Those skilled in the art will be able to implement the above-described details.
The foregoing description of the preferred embodiments of the invention is not intended to be limiting, but rather is intended to cover all modifications, equivalents, and alternatives falling within the spirit and principles of the invention.
Claims (8)
1. An ophthalmic lens for improving amblyopia or preventing astigmatism and vision deterioration is characterized in that the lens is provided with a light zone S1, and the periphery of the light zone S1 is a peripheral light zone S2; the optical zone S1 is a full-correction lens with refractive errors, and comprises a far-vision or near-vision full-correction lens with first astigmatism; the diopter B of the far-sight or near-sight full-correction foot lens is larger than or equal to a conventional optometry value, the diopter of the first astigmatism full-correction foot lens is kDC, and the value range of k is-8 to +8, and k is not 0; the peripheral light area S2 is a first non-corrective lens, and the diopter B1 of the first non-corrective lens is as follows: (1/2) kDS < B1 < +10DS to eliminate abnormal back accommodation of the eye; or: the surrounding light area S2 is a second astigmatic full-correction lens and a second non-correction lens, the astigmatic degree of the second astigmatic full-correction lens is the same as or basically the same as that of the first astigmatic full-correction lens, and the diopter B2 of the second non-correction lens is in the range of 0.25 DS-10 DS; the total area of the spectacle lens is more than 900 square millimeters.
2. The full-length, amblyopia-improving or astigmatism-preventing and vision deterioration ophthalmic lens according to claim 1 wherein the overcorrection range for distance vision is an increase of conventional refraction values of 0DS to +0.5ds; the overcorrection range of near vision is the conventional refraction value increased by 0DS to-0.5 DS.
3. The full-length, amblyopia-improving or astigmatism-preventing and vision deterioration ophthalmic lens according to claim 1 wherein: the area of the light region S1 is less than 700 square millimeters.
4. The full-length ophthalmic lens of claim 2, wherein the lens is effective to improve amblyopia or prevent astigmatism and vision deterioration, and wherein the lens is further effective to: the area of the light region S1 is less than 600 square millimeters.
5. A full-length glasses lens for improving amblyopia or preventing astigmatism and vision deterioration, comprising 2 glasses lenses for improving amblyopia or preventing astigmatism and vision deterioration according to any one of claims 1 to 4, and the 2 glasses lenses are integrated into one large lens.
6. An ophthalmic lens for full correction to improve amblyopia or prevent astigmatism and vision deterioration according to claim 5 characterized in that the lower part is provided with a structure fitting the nose; the spectacle lens is a press-fit spectacle lens or a Fresnel lens.
7. Glasses for improving amblyopia or preventing astigmatism and vision deterioration comprising the glasses for improving amblyopia or preventing astigmatism and vision deterioration according to any one of claims 1 to 4.
8. A therapeutic apparatus for improving amblyopia or preventing astigmatism and vision deterioration comprising the full-length glasses lens for improving amblyopia or preventing astigmatism and vision deterioration according to any one of claims 1 to 6, said therapeutic apparatus comprising: a desk-type read-write instrument, a read-write myopia prevention instrument or a therapeutic instrument with a bracket, which is arranged on a desk.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811139815.2A CN108957787B (en) | 2018-09-28 | 2018-09-28 | Full-correction glasses lens for improving amblyopia or preventing astigmatism and vision deterioration and therapeutic apparatus |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811139815.2A CN108957787B (en) | 2018-09-28 | 2018-09-28 | Full-correction glasses lens for improving amblyopia or preventing astigmatism and vision deterioration and therapeutic apparatus |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN108957787A CN108957787A (en) | 2018-12-07 |
| CN108957787B true CN108957787B (en) | 2024-10-15 |
Family
ID=64472229
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201811139815.2A Active CN108957787B (en) | 2018-09-28 | 2018-09-28 | Full-correction glasses lens for improving amblyopia or preventing astigmatism and vision deterioration and therapeutic apparatus |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108957787B (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN201749260U (en) * | 2010-07-12 | 2011-02-16 | 段亚东 | Myopia progressive addition peripheral defocus correction spectacles |
| CN204679732U (en) * | 2015-04-15 | 2015-09-30 | 黄舸 | A kind of mini eyeglass and comprise the glasses of this eyeglass |
| CN208721922U (en) * | 2018-09-28 | 2019-04-09 | 戴明华 | Full foot of rectifying improves amblyopia or prevents the spectacle lens and therapeutic equipment of astigmatism and deteriorating vision |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6582076B1 (en) * | 2000-08-30 | 2003-06-24 | Johnson & Johnson Vision Care, Inc. | Ophthalmic lenses useful in correcting astigmatism and presbyopia |
| JP3881221B2 (en) * | 2001-11-16 | 2007-02-14 | 石根 三井 | Contact lenses for myopia and / or astigmatism correction |
| FR2884325B1 (en) * | 2005-04-08 | 2007-06-01 | Essilor Int | OPHTHALMIC LENS |
| CN101387762A (en) * | 2008-08-08 | 2009-03-18 | 董景龄 | Partial thin layer multi-focus glasses |
| CN102692730B (en) * | 2012-06-15 | 2013-12-04 | 戴明华 | Multi-element lens for controlling defocus and eye diopter and application thereof |
| WO2014026153A1 (en) * | 2012-08-10 | 2014-02-13 | Pixeloptics, Inc. | Dynamic ophthalmic lens capable of correcting night and day vision |
| CN106062616B (en) * | 2014-04-01 | 2019-04-12 | 依视路国际公司 | It is arranged to the multifocal ophthalmology spectacle lens for exporting supplemental image |
| US9733494B2 (en) * | 2014-08-29 | 2017-08-15 | Johnson & Johnson Vision Care, Inc. | Free form lens design and method for preventing and/or slowing myopia progression |
| BR112018006968A2 (en) * | 2015-10-15 | 2018-10-16 | Essilor Int | ophthalmic progressive addition lens for a presbyopic wearer; method for providing this lens |
-
2018
- 2018-09-28 CN CN201811139815.2A patent/CN108957787B/en active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN201749260U (en) * | 2010-07-12 | 2011-02-16 | 段亚东 | Myopia progressive addition peripheral defocus correction spectacles |
| CN204679732U (en) * | 2015-04-15 | 2015-09-30 | 黄舸 | A kind of mini eyeglass and comprise the glasses of this eyeglass |
| CN208721922U (en) * | 2018-09-28 | 2019-04-09 | 戴明华 | Full foot of rectifying improves amblyopia or prevents the spectacle lens and therapeutic equipment of astigmatism and deteriorating vision |
Also Published As
| Publication number | Publication date |
|---|---|
| CN108957787A (en) | 2018-12-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2694777C2 (en) | Design of lens with central treatment area with high positive optical power and method for preventing and/or slowing progression of myopia | |
| US6752499B2 (en) | Myopia progression control using bifocal contact lenses | |
| TWI665490B (en) | High plus treatment zone lens design for preventing and/or slowing myopia progression | |
| US7766478B2 (en) | Contact lens and method for prevention of myopia progression | |
| RU2724357C2 (en) | Contact lens comprising non-coaxial elementary lenses for preventing and/or slowing the progression of myopia | |
| Chua et al. | The economic and societal impact of myopia and high myopia | |
| Lau et al. | Weekly changes in axial length and choroidal thickness in children during and following orthokeratology treatment with different compression factors | |
| CN108957788B (en) | Grid-type defocused eyeglass lens and therapeutic device for inhibiting eye axis growth | |
| CN208721922U (en) | Full foot of rectifying improves amblyopia or prevents the spectacle lens and therapeutic equipment of astigmatism and deteriorating vision | |
| CN108957787B (en) | Full-correction glasses lens for improving amblyopia or preventing astigmatism and vision deterioration and therapeutic apparatus | |
| CN108957789B (en) | Eyeglass lens and therapeutic device for preventing asymmetric visual field from causing refractive deterioration and visual fatigue | |
| CN111743741B (en) | Axial refractive index difference type amblyopia reducing and difference training method and device | |
| CN208847987U (en) | The grid type defocus spectacle lens and therapeutic equipment for inhibiting axis oculi to increase | |
| DULING et al. | Binocular vision complications after radial keratotomy | |
| Barrado-Navascúes et al. | Vision evolution in the treatment of nystagmus with hydrophilic contact lenses (two clinical cases) | |
| CN208384274U (en) | A kind of bifocals piece and the glasses using the spectacle lens | |
| Mitusheva et al. | CONTROL OF MYOPIA | |
| Saidahror et al. | EYE DISEASES IN MEDICINE | |
| WO2024206234A2 (en) | Multifocal orthokeratology contact lens | |
| Key | Error (Myopia, Hyperopia, Astigmatism) | |
| RU9721U1 (en) | DEVICE FOR STABILIZING ACUTE VISION | |
| HK40032875B (en) | Medical device and method for management of ocular axial length growth in the context of refractive error evolution | |
| Dhankhoti¹ et al. | Visual Rehabilitation with Scleral Lens in a High Myopic Eye Initially Diagnosed as Amblyopia: Case Report | |
| Bezditko et al. | Refraction | |
| Street et al. | Myopia Control |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |